IC
MBIO icon

Ikarian Capital’s Mustang Bio MBIO Stock Holding History

Ikarian Capital’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-329
Closed -$145K – 142
2022
Q2 		$145K Sell
329
-400
-55% -$221K 0.03% 126
2022
Q1 		$551K Buy
729
+54
+8% +$44.4K 0.07% 132
2021
Q4 		$840K Hold
675
– – 0.13% 105
2021
Q3 		$1.36M Sell
675
-26
-4% -$55.9K 0.1% 145
2021
Q2 		$1.75M Hold
701
– – 0.14% 139
2021
Q1 		$1.75M Hold
701
– – 0.06% 211
2020
Q4 		$1.99M Sell
701
-374
-35% -$894K 0.09% 156
2020
Q3 		$2.54M Buy
1,075
+600
+126% +$1.48M 0.18% 102
2020
Q2 		$1.13M Hold
475
– – 0.09% 119
2020
Q1 		$955K Buy
475
+44
+10% +$113K 0.07% 122
2019
Q4 		$1.32M Buy
+431
New +$987K 0.21% 74

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital's MBIO Position: Q3 2022 in Review

Ikarian Capital sold out of Mustang Bio (MBIO) in Q3 2022, closing a stake of 329 shares — an estimated $145K sold.

Ikarian Capital first reported a position in MBIO in Q4 2019 and held it in 11 quarters. The position peaked at $2.54M in Q3 2020. 67 funds tracked by Wall St. Rank hold MBIO as of Q3 2022.

  • Ikarian Capital reported no remaining Mustang Bio position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 329 Mustang Bio shares in Q3 2022, an estimated $145K.
  • Ikarian Capital first reported a position in Mustang Bio in Q4 2019 and held it in 11 quarters.
  • Ikarian Capital's Mustang Bio position peaked at $2.54M in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.